|
Delayed
Hong Kong S.E.
07:59:55 04/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 11.73 HKD | -0.34% |
|
+3.81% | -2.01% |
| 05:26am | Simcere Pharma's Yingmule Gets China Marketing Approval for RSV Prevention | MT |
| 09-03 | Hutchmed Enters Licensing Agreement With GSK for Cancer Drug | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SIMCERE PHARMACEUTICAL GROUP LIMITED | Generic Pharmaceuticals | -0.34% | +3.81% | -2.01% | -12.79% | +45.90% | 3.86B |  |  | |
- Stock Market
- Stocks
- 2096 Stock
- Charts Simcere Pharmaceutical Group Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
